Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NTS-521 in Early Recovery Treatment From Acute Ischemic Stroke
NCT07742098Phase 2Not yet recruiting
- Sponsor
- NeuroTrauma Sciences
- Start
- Oct 2026
- Primary completion
- Dec 2028
01
Overview
A Phase 2 trial of NTS-521 in ischemic stroke, sponsored by NeuroTrauma Sciences. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
NTS-521
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07742098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07742098.